Agilent Technologies (Oligo GMP)
Santa Clara, CA
Reagent / Material Supplier
No confirmed program data — ClinicalTrials.gov verification pending
· Last scored 2026-09-07
74.2
Signal Score
✓ FDA Inspections (2)
✓ Clinical Trials (1)
○ SEC Filings
○ Press
○ EMA GMP
○ MHRA GMP
Quick Facts: Agilent Technologies (Oligo GMP)
- Signal Score
- 74.2/100 (as of 2026-09-07)
- Quality Compliance
- 100.0/100
- Headquarters
- Santa Clara, CA
- Modalities
- Oligonucleotide
- Active Programs
- Data pending
- Data Sources
- FDA Data Dashboard, ClinicalTrials.gov, SEC EDGAR, press monitoring
- Scored By
- CDMO Signal — independent CDMO intelligence platform
About Agilent Technologies (Oligo GMP)
Reagent/raw material supplier.
Signal Score & Pillar Breakdown
Scores are being republished.
Scores are being republished under methodology v3.3. The score shown is the last complete v3.2 result, which is also what directory listings and search results show. A pillar breakdown is not shown because the current one is computed under v3.3 and would not explain a v3.2 score. Regulatory evidence below is current.
Quality Compliance
100.0
FDA Inspections2 on record
Warning Letters0
Last InspectionNo Action Indicated (NAI) (2026-05-06)
Operations
60.0
Programs
— no verified data
Sponsors— no verified data
ModalitiesOligonucleotide
Data sourced from ClinicalTrials.gov, FDA, SEC EDGAR, and verified press only. No unverified estimates shown.
Source: ClinicalTrials.gov · Retrieved Oct 06, 2026
Financial Stability
68.0
Profile-based financial assessment
SEC FilingsPrivate company
Capacity
53.0
Profile-based capacity assessment
Agilent Technologies (Oligo GMP) FDA Inspection History
2026-05
2025-06
NAI
VAI
OAI
| Date | Site | Type | Observations | Classification |
|---|---|---|---|---|
| 2026-05-06 |
Agilent Technologies Inc
Boulder, Colorado
Facility-linked
|
Drug Quality Assurance | No | No Action Indicated (NAI) |
| 2025-06-18 |
Agilent Technologies Inc
Frederick, Colorado
Facility-linked
|
Drug Quality Assurance | No | No Action Indicated (NAI) |
Source: FDA Data Dashboard · Retrieved Oct 06, 2026
Clinical Activity 1 studies
Source: ClinicalTrials.gov · Retrieved Oct 06, 2026
Frequently Asked Questions About Agilent Technologies (Oligo GMP)
How many FDA inspections does Agilent Technologies (Oligo GMP) have on record?
CDMO Signal tracks 2 FDA inspections for Agilent Technologies (Oligo GMP), sourced from the FDA inspection database. See the full inspection history above.
Has Agilent Technologies (Oligo GMP) received an FDA warning letter?
CDMO Signal has no FDA warning letters on record for Agilent Technologies (Oligo GMP).
How many clinical programs is Agilent Technologies (Oligo GMP) linked to?
Agilent Technologies (Oligo GMP) is associated with 1 clinical trial in CDMO Signal's ClinicalTrials.gov-sourced data.
What is Agilent Technologies (Oligo GMP)'s CDMO Signal Score?
Agilent Technologies (Oligo GMP) has a Signal Score of 74/100, based on quality, operations, financial stability, and capacity data.
Evaluating Agilent Technologies (Oligo GMP) for a manufacturing program?
Use the free AI matchmaker to compare Agilent Technologies (Oligo GMP) against other CDMOs by FDA, EMA, and clinical-trial data — no login required.
Find & compare CDMOs →
Represent this organization? Contact us to verify or update this profile.
See all CDMOs in:
Similar CDMOs
Ajinomoto Bio-Pharma Services
San Diego, CA · Osaka, JP
Signal Score: 83.5
Oligonucleotide, Biologics, AAV
TriLink BioTechnologies
San Diego, CA
Signal Score: 71.0
mRNA, Oligonucleotide
PolyPeptide Group
Torrance, CA · Strasbourg, FR · Malmo, SE
Signal Score: 66.1
Oligonucleotide
LGC Biosearch Technologies
Petaluma, CA · Middleton, WI
Signal Score: 63.0
Oligonucleotide
Hongene Biotech
Singapore (primary operations: Union City, CA / Shanghai, China)
Signal Score: 56.5
Oligonucleotide